Skip to content
Celebrity

What Hone Health's $228 Million Raise Includes: Just $28 Million in Equity

Jay-Z's MarcyPen led the $28 million equity portion of Hone Health's $228 million package, announced Nov. 18, 2026, with the rest from a revenue-linked facility.

Wood double doors under a 40/40 Club sign on a cream stone facade, with potted shrubs on the sidewalk.

Hone Health announced on Wednesday, Nov. 18, 2026, that it had raised $228 million in new financing. The physician-led online clinic began by treating men with low testosterone. Only $28 million of the money is equity.

The equity portion was led by MarcyPen Capital Partners, a firm co-founded by Jay-Z. Celebrity investors in the round include the Jonas Brothers, Kelly Rowland and Marcello Hernández. Kinship Ventures, the firm co-founded by Gwyneth Paltrow, also took part. Hone's total equity funding is now $65 million.

What the $228 Million Is Made Of

The package has two parts. The first is $28 million of equity. Hone's press release describes it as a Series A financing, and Fortune describes it as an extension of the Series A. The release says the round follows a $33 million Series A that was announced in January 2025.

The second part is $200 million of growth financing from General Catalyst's Customer Value Fund. Fortune reports that this money is repaid from a share of the revenue or profit that new patients generate.

Fortune reports that Saad Alam can request $10 million a month from General Catalyst and spend it on acquiring patients. Alam told Fortune most of the $28 million equity will go to AI tools that let one physician handle problems that would otherwise need several specialists.

Who Led the Equity Round

Fortune reports that MarcyPen Capital Partners was co-founded by Jay-Z, Jay Brown, and Robbie and D'Rita Robinson. The firm formed in 2024 when Jay-Z's Marcy Venture Partners merged with the investment arm of Pendulum Holdings. The press release says MarcyPen had already led Hone's Series A, a role that had not been disclosed before.

The release says MarcyPen has partnered with Hone for more than two years and has continued to support the company with follow-on investments. Jay Brown, a co-founder and managing partner at MarcyPen, said the firm was proud to deepen its partnership with Hone.

Kinship Ventures, which Paltrow co-founded with Moj Mahdara, took part in the equity round. Other equity backers named in the announcements include Pentland Ventures, Hanwha, Gannet Capital, Humbition, Comma Capital and ID Ventures.

Omar Hatteea, an investment manager at Pentland Ventures, said Hone's physicians stay with patients over years. The release ties that to Pentland's thesis about a health operating system.

The Celebrity and Individual Investors

Fortune lists the Jonas Brothers (Nick, Joe and Kevin Jonas), Kelly Rowland, Marcello Hernández, David Grutman, Jason Strauss, Noah Tepperberg and Quentin Dolan among individual investors. The release instead describes the Jonas Brothers, Hernández, Braxton Berrios, Rowland, Strauss and Tepperberg as strategic investors that Grutman brought in.

The release describes Grutman as a strategic investor and advisor. It also names former NBA player Josh Childress, Raj Gokal, Tushar Jain, Kyle Samani, Halle Tecco and Zachary Gordan among other investors.

Fortune reports that Strauss has been interested in longevity medicine for decades.

Fortune reports that Paltrow said she is also a patient of Hone. The release quotes her, as founder and CEO of goop, on wellness moving into the mainstream. Moj Mahdara of Kinship said Hone's data from more than 200,000 patients helps its physicians improve with each patient.

How Customer Value Fund Financing Works

TechCrunch's May 1, 2026 report on Musely, which received more than $360 million from the same fund, describes the structure. The fund provides capital for customer acquisition, such as sales and marketing spending. TechCrunch reports that the fund's investors approached Musely in 2025, and that its CEO, Jack Jia, found the terms compelling after modeling them.

According to TechCrunch, companies repay the principal along with a fixed percentage of the revenue generated with the money, and that percentage has a cap. According to TechCrunch, the fund did not take an equity stake in Musely or offer it a loan that would carry interest rate charges.

Fortune's account of Hone's terms differs from TechCrunch's on interest. Alam told Fortune the interest rate is very small, and Fortune reports that repayment includes interest. Fortune describes the repayment base as profit in one passage and as revenue in another.

Alam told Fortune that, unlike a bank loan, the deal has no recourse and no covenants restricting Hone from raising other money. Alam said General Catalyst offers it only to companies whose patients stay at a steady rate. TechCrunch reports that the fund has its own limited partners and that its capital was not part of General Catalyst's most recent $8 billion fundraise. Its portfolio includes Grammarly, Lemonade and Ro.

“Only $28 million of the money is equity.”

What Hone Does and What the Money Funds

Fortune reports that Saad Alam co-founded Hone in 2020 and that the company started by treating men with low testosterone. Hone describes itself as a physician-led longevity platform. Fortune says it has treated about 200,000 patients since launch, up from 55,000 in January 2025. Alam told Fortune that Hone broke through $100 million in recurring revenue last year.

Fortune says Alam, at 35, told his doctor he was depressed and gaining weight despite eating well, sleeping well and being an athlete. After months of visits to endocrinologists, urologists and cardiologists, doctors diagnosed low testosterone.

The press release says the new money will fund five areas. These are broader clinical care in metabolic health, PMOS, inflammation and immunity; advanced diagnostics, including full-body MRI, DEXA scans, coronary CT angiography and gut microbiome analysis; AI tools that combine labs, history, symptoms, medications and outcomes; a physician-supervised peptide program where legally available; and clinical trial infrastructure. The release says that trial work is meant to show which care drives the best outcomes.

The release describes Hone Black, a concierge membership that pairs more than 1,600 health markers with a dedicated physician team responsible for whole-body care. Treatments include prescription medications, supplements, peptides, lifestyle guidance, and exosome and stem cell therapies. Fortune reports that Alam calls it a test bed for treatments that may later reach Hone's main product. The release says Hone will publicly launch Hone Black after running in stealth for the past year, while Fortune says Hone is also launching it.

The Plan Hone Has Described

Fortune reports that Alam describes a three-stage plan. The first stage is to build a large online clinic. The second is to run remote clinical trials using the patient base. The third is to partner with drugmakers and research centers to bring drugs to market faster, in exchange for equity.

The release says Hone has treated more than 200,000 patients, administered 750,000 tests and processed 25 million health markers. Since the $33 million Series A, it has launched a cardiovascular program that integrates Prenuvo whole-body MRI and BodySpec DEXA scans. Alam said in the release that people are looking for the highest level of insight into their metrics.

Alam told Fortune that Hone is the first business under a parent company, Time Therapeutics. The round was announced on Nov. 18, 2026.

Related